Gene · 8321
Papers2,162
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 2,162
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Engineered LINC MIR503HG-loaded extracellular vesicles maintain stemness and pluripotency during long-term hiPSCs culture. | Bioact Mater | 2026 | 41551196 | PubTator, text mining | PubMed |
| Histone deacetylase SIRT2 regulates the development and metastasis of tongue cancer via FZD1-mediated Wnt/β-catenin pathway. | Toxicol Appl Pharmacol | 2026 | 41485500 | PubTator, text mining | PubMed |
| Frizzled-1 amplification promotes fibrosis in the gastric tumor microenvironment through the activation of fibroblasts via the SLIT2/ROBO1 axis. | Gastric Cancer | 2026 | 41484652 | PubTator, text mining | PubMed |
| Clinicopathologic and prognostic significance of TIAM2 overexpression in resected hepatocellular carcinoma. | Future Sci OA | 2025 | 41328861 | PubTator, text mining | PubMed |
| Targeting FZD6 creates therapeutically actionable vulnerabilities for advanced prostate cancer. | Oncogene | 2025 | 41286306 | PubTator, text mining | PubMed |
| Wnt/β-catenin signaling regulates cardiac Cx43 in a metabolic substrate-dependent manner. | J Mol Cell Cardiol Plus | 2025 | 41098661 | PubTator, text mining | PubMed |
| The E3 ubiquitin ligase ZNRF3 restricts WNT receptor complex activity by stimulating the selective degradation of WNT-engaged FZD. | Sci Signal | 2025 | 41086253 | PubTator, text mining | PubMed |
| Deciphering the Structural Biology of GFAP: Connotations of Its Potency in Presaging the Diagnosis for Traumatic Brain Injury and AD. | Neurol Int | 2025 | 41002922 | PubTator, text mining | PubMed |
| Novel insights into the relationship between glaucoma and brain diseases from the genetic to diseases levels: A cross-sectional study. | Medicine (Baltimore) | 2025 | 40988281 | PubTator, text mining | PubMed |
| Triazolo-indazole-trione-mediated disruption of Wnt/β-catenin pathway drives both autophagic and paraptotic cell deaths in colorectal cancer cells. | Pathol Res Pract | 2025 | 40975003 | PubTator, text mining | PubMed |
| Engineering Spatial and Molecular Features from Cellular Niches to Inform Predictions of Inflammatory Bowel Disease. | ArXiv | 2025 | 40964085 | PubTator, text mining | PubMed |
| Evaluation of De Novo Deep Learning Models on the Protein-Sugar Interactome. | bioRxiv | 2025 | 40950156 | PubTator, text mining | PubMed |
| Local Expression of Epigenetic Candidate Biomarkers of Adolescent Idiopathic Scoliosis Progression. | Int J Mol Sci | 2025 | 40943383 | PubTator, text mining | PubMed |
| Cyclic Heptapeptide FZ1 Acts as an Integrin αvβ3 Agonist to Facilitate Diabetic Skin Wound Healing by Enhancing Angiogenesis. | J Med Chem | 2025 | 40910702 | PubTator, text mining | PubMed |
| The interplay between Wnt and mTOR signaling modulates ciliogenesis in human retinal epithelial cells. | PLoS Biol | 2025 | 40892854 | PubTator, text mining | PubMed |
| Wnt signaling - using the bloodstream to send a message. | Cell Mol Life Sci | 2025 | 40879783 | PubTator, text mining | PubMed |
| JCAD-Derived from Plasma Exosomes: Promoting Tumor Cell Progression and Predicting Poor Outcomes in Breast Cancer. | Int J Biol Sci | 2025 | 40860197 | PubTator, text mining | PubMed |
| Molecular signatures underlying heterogenous hypertrophy responsiveness to resistance training in older men and women: a within-subject design. | J Appl Physiol (1985) | 2025 | 40839394 | PubTator, text mining | PubMed |
| METTL3 and METTL14 drive pancreatic adenocarcinoma progression via m6A-dependent alternative splicing in PANC-1 cells. | Discov Oncol | 2025 | 40836174 | PubTator, text mining | PubMed |
| Integrative proteogenomic characterization of Wilms tumor. | Nat Commun | 2025 | 40830093 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8321/papers?page=2